Search results

2 items
  1. Corporate capture of the Latin American medical cannabis market

    • Paulo José dos Reis Pereira
    31 October 2022
    Policy briefing

    This report analyses the role of transnational cannabis corporations in the context of the market created by the new regulations on cannabis for medicinal purposes in Latin America and the Caribbean.

  2. Report on the Caribbean Informal Drug Policy Dialogue on the Future of Cannabis

    17 June 2022
    Report

    The Caribbean region’s Informal Drug Policy Dialogue that was held in Kingstown, St. Vincent and the Grenadines (SVG), in December 2021, at the initiative of Transnational Institute (TNI) in close collaboration with the Medicinal Cannabis Authority (MCA) of SVG highlighted several challenges to the establishment of a legal medical cannabis industry currently being faced by countries in the region. These issues include international banking restrictions; access to laboratory, research and testing facilities; complying with EU GACP and GMP to meet the standards for exports, the Seed-to-Sale System; securing access for patients and getting doctors to prescribe; the structure of the licensing system; guarantees for the Rastafari community for ceremonial ganja usage, and most importantly, how to envisage traditional cultivators inclusion in the regulatory framework and practice being developed.  Around the table seven (7) countries were represented from the region: Barbados, Grenada, St. Kitts and Nevis, Antigua and Barbuda, Jamaica, St Lucia and of course St Vincent and the Grenadines.